No Data
Moderna, Sarepta, Biotech Stocks Sink After Top FDA Official Resigns
U.S. stock market fluctuations | A well-known FDA official resigned, causing Moderna (MRNA.US) to drop nearly 9%.
Vaccine giant Moderna and gene therapy company Sarepta Therapeutics fell nearly 9%, reporting prices of $28.34 and $64.09 respectively.
Sarepta Downgraded at RBC Capital on Gene Therapy Concerns
Vaccine Stocks Fall After Ousting of FDA's Vaccine Head
Express News | Solid Biosciences Down 10.5%, Taysha Gene Therapies Down 14%
Express News | Sarepta Therapeutics Down 6.2%, Beam Therapeutics Down 10.2%, U.S.-Listed Shares of CRISPR Therapeutics Down 6.2%
